Matches 1 - 50 out of 91 1 2 >
Match Document Document Title
7572782 Use of targeted oxidative therapeutic formulation in bone regeneration  
A pharmaceutical formulation and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an...
7572798 Combi-molecules having signal transduction inhibitory properties and DNA damaging properties  
The present invention relates to a series of new chemical agents that demonstrate anti-tumor activity. More particularly, the present invention relates to molecules, referred to as...
7544306 Azeotropic fumigant compositions of methyl iodide  
Azeotropic and azeotrope-like compositions of methyl iodide and at least one fluorocarbon or hydrofluorocarbon such as 1,1,1,3,3-pentafluoropropane (HFC-245fa). The compositions are present as a...
7488854 Diterpenoid compounds imparting stress resistance to plants  
The present invention provites a compound having the following structure: wherein, in the formula: X is selected from the group consisting of hydroxy, substituted hydroxy, halogen, thiol,...
7378449 Poly(bromoaryl)alkane additives and methods for their preparation and use  
An additive mixture useful as a flame retardant is described. The mixture is comprised of (i) a poly(bromophenyl)alkane having in the molecule in the range of 13 to 60 carbon atoms and in the range...
7220784 Substituted stilbenes and their reactions  
The present invention relates to stilbene and quinone compounds related to combretastatin A-4 and their use as anticancer compounds and prodrugs. The compounds include those with an alkyl group on...
7074434 Process for the separation of a mixture comprising at least one hydrofluoroalkane and hydrogen fluoride, processes for the preparation of a hydrofluoroalkane and azeotropic compositions  
Process for the separation of a mixture comprising at least one hydrofluoroalkane and hydrogen fluoride, according to which a hydrofluoroalkane/hydrogen fluoride mixture is reacted with at least...
7026359 Utilization of a highly fluorinated oligomeric alkane in ophthalmology  
The invention relates to the utilization of a highly fluorinated oligomeric alkane as a therapeutic agent in ophthalmology, the alkane having the general formula [—R F (CH 2 ) n CR 1 —CR 2 —]...
6927237 Two solvent antimicrobial compositions and methods employing them  
The present invention relates to two solvent antimicrobial compositions and methods employing these two solvent compositions. The two solvent compositions typically contain a second solvent that is...
6861451 Carboxylic acid fluorides as pesticides  
Carboxylic acid fluorides having a boiling point of preferably less than 100° C. are suitable for use as pesticides. Acetyl fluoride is highly suitable, and Chlorodifluoroacetyl fluoride and...
6528545 Preparations comprising a fluorocarbon or highly fluorinated compound and a lipophilic/fluorophilic organic compound, and their uses  
Fluorocarbon emulsions comprising a stabilizing, particle size controlling fluorophilic/hydrophilic compound which can have the formula R F 1 —W—R H 1 (I) wherein R F 1 is a linear,...
6465527 Iodinated hydrocarbon pesticide  
Disclosed is both a method and composition for controlling deleterious organisms, such as insects, nematodes and weeds by applying a compound comprised of both mono-iodinated hydrocarbons and...
6423330 Pesticidal composition and method  
A mammalian pesticidal composition, and in particular a pesticidal composition for the control of insectivores, in which a pesticidal agent comprising one or more low molecular weight halogenated...
6420436 Imaging contrast media and methods of use  
This invention relates to a non-aqueous fluorocarbon composition for use in magnetic resonance imaging (MRI) or radiographic imaging (X-ray or computed tomography), particularly imaging of the...
6300378 Tropodegradable bromine-containing halocarbon additives to decrease flammability of refrigerants foam blowing agents solvents aerosol propellants and sterilants  
A set of tropodegradable chemical additives to decrease the flammability of normally flammable refrigerants, foam blowing agents, cleaning solvents, aerosol propellants, and sterilants is...
6267945 Farnesol-related calcium channel blockers  
Compounds comprising a straight backbone carbon chain of 8-16C, optionally substituted with 1-5 alkyl groups (1-6C); said chain optionally functionalized at one terminus with halo, --OR,...
6211248 Fluorinated alkanes and their uses  
The invention concerns a partially fluorinated alkane with the general formula R F [CF 2 --CH 2 ]R H , wherein R H is a substituent of the general formula C n H x selected from the group...
6204296 Patient oxygenation using stabilized fluorocarbon emulsions  
Storage stable fluorocarbon emulsions having a continuous aqueous phase and a discontinuous fluorocarbon phase, in which the fluorocarbon phase comprises a major amount of a first fluorocarbon or...
6127428 Method for enhancing transport of gases to tissues  
A method is disclosed for the treatment of right to left shunt. The method comprises introducing, into the blood circulation of an individual, to be treated, a therapeutically effective amount of...
6124357 Iodinated fatty acid esters iodinated fatty acids and derivatives thereof produced by iodohydrination using alkylsilylated derivatives and alkaline iodides and the pharmacological activities thereof  
6028117 Microemulsion insect control compositions  
Disclosed herein are microemulsion insecticides that do not contain conventional actives. The microemulsion form permits insects to be killed by an oil/surfactant combination.
6008209 Method of using vitamin D.sub.3 analogs with bis C-20 side chains  
This invention provides a method of treating or preventing neoplastic diseases. The method comprises adminstering to a host in need of such treatment or prevention an effective amount of a Vitamin...
5989918 ADME analysis of mixtures  
A method for analyzing the ADME/PK properties of a mixture of compounds is (1) perfusing an animal or organ with a perfluorocarbon emulsion blood substitute, (2) administering the mixture of test...
5985310 Preservative systems for pharmaceutical compositions containing cyclodextrins  
Disclosed are preservative systems useful in aqueous pharmaceutical compositions containing an active agent and a cyclodextrin. The preservative systems comprise boric acid and one or more...
5916882 Povidone iodine (PVP-I) alcohol gel antimicrobial pre-operative skin preparation  
The present invention provides antimicrobial skin-preparations useable to disinfect a surgical site for surgery. The antimicrobial skin-preparation formula includes iodine, alcohol and gel. The new...
5914352 Methods for the use of stabilized fluorocarbon emulsions  
Storage stable fluorocarbon emulsions having a continuous aqueous phase and a discontinuous fluorocarbon phase, in which the fluorocarbon phase comprises a major amount of a first fluorocarbon or...
5874113 Shelf life improvement for ethylene oxide sterilant mixes  
A method of increasing the shelf life of a sterilant mixture of ethylene oxide and one or more halocarbons when the mixture is in contact with iron oxide on the surface of a storage vessel....
5869538 Method for enhancing transport of gases to tissues  
Disclosed are methods of using stabilized microbubbles, such as those formulated from slowly permeating gas, to deliver or remove from tissue at least one gas selected from a respiratory gas,...
5869539 Emulsions of perfluoro compounds as solvents for nitric oxide (NO)  
The present invention involves perfluoro compound emulsions including nitric oxide, their preparation and their use. These emulsions provide a new source of nitric oxide. Such nitric...
5859068 Acceleration of tissue growth using fluorocarbon liquid  
A method for the acceleration of tissue growth using continuous fluorocarbon liquid-based positive pressure is disclosed, whereby significant increase in tissue growth is achieved.
5847009 Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions  
Methods for preventing or ameliorating the transient adverse physiological response to particulate dispersions (TAPR response) when these dispersions are administered parenterally to a patient. The...
5824703 Method of assisting normal breathing in a mammal having a lung disorder  
A method of assisting a mammal having a lung disorder to breathe ambient gas normally, i.e., without the assistance of a ventilator. The method includes providing an animal having a lung disorder,...
5733939 Fluorocarbons as anti-inflammatory agents  
A method for reducing the inflammatory response in tissues of a patient, by contacting the tissue with an effective, inflammation-reducing amount of a liquid or gaseous fluorocarbon.
5705148 Use of hydro- and fluorocarbon compounds in cosmetic compositions; hydro- and fluorocarbon compounds; and cosmetic compositions containing these compounds  
The present invention concerns the use of hydrofluorocarbon compounds with formula (I): R F -(CH 2 ) n -X- C 3 H 5 (OH)!-Y-(CH 2 ) m -R' F ...
5684050 Stable emulsions of highly fluorinated organic compounds  
Stable emulsions of highly fluorinated organic compounds for use as oxygen transport agents, "artificial bloods" or red blood cell substitutes and as contrast agents for biological imaging. The...
5635538 Fluorocarbon emulsions with reduced pulmonary gas-trapping properties  
A fluorocarbon emulsion which exhibits reduced pulmonary gas-trapping properties in species-sensitive laboratory animals is disclosed. Additionally, the fluorocarbon component(s) exhibit short...
5628930 Stabilization of fluorocarbon emulsions  
Storage stable fluorocarbon emulsions having a continuous aqueous phase and a discontinuous fluorocarbon phase, in which the fluorocarbon phase comprises a major amount of a first fluorocarbon or...
5573757 Viscoelastic compositions containing concentrated fluorinated compounds their method of preparation and their uses  
Compositions for topical application in gel form comprising a fluorocarbon or perfluorocarbon compound or mixtures thereof at a concentration of at least about 75% v/v, a minor quantity of a...
5480914 Nonaqueous thixotropic drug delivery suspensions and methods of their use  
Nonaqueous thixotropic drug delivery vehicles for use in aqueous physiological systems are disclosed comprising a substantially homogeneous dispersion of at least one suspending aid in a nonaqueous...
5459126 Method for decreasing calcium uptake by cells using selected polycations  
A method for reducing calcium overload in cells to prevent the transition from reversible to irreversible injury. The cell surface is treated with an organic polycation selected from the group...
5439944 Red blood cell substitute emulsions containing alkyl- or alkylglyucerophosphoryl choline surfactants and methods of use  
Oil and water emulsions containing alkylphosphoryl choline or alkylglycerophosphoryl choline surfactants are disclosed. The surfactants have the following general structures: ##STR1## In the above...
5409688 Gaseous ultrasound contrast media  
Disclosed herein are agents for enhancing the contrast in an ultrasound image. These agents are extremely small bubbles, or "microbubbles," comprised of specially selected gases. The microbubbles...
5385721 Compositions of alkylbenzenes and cellulose derivatives for visualization of the gastrointestinal tract  
Disclosed are x-ray contrast compositions for oral or retrograde examination of the gastrointestinal tract comprising an x-ray producing agent of the formula or a pharmaceutically acceptable salt...
5376333 Ethylene oxide-carrier gas compositions having improved flammability suppressant characteristics  
Compositions of ethylene oxide and monochlorotetrafluoroethane which are useful as sterilizing agents. These novel compositions are environmentally acceptable, possess improved flammability...
5236694 19F labelled dextrans and antibodies as NMR imaging and spectroscopy agents  
19 F labelled compounds are disclosed which are useful in methods of NMR imaging and spectroscopy. The compounds comprise a 19 F-containing sensor moiety, and a transport polymer or substrate,...
5234680 Perfluoro-t-butyl-containing compounds for use in fluorine-19 NMR and/or MRI  
The present invention is directed to biological compounds derivatized so as to contain at least one perfluoro-t-butyl moiety for use in fluorine-19 NMR and/or MRI studies. The perfluoro-t-butyl...
5141739 Delivery of x-ray contrast agents using receptor mediated endocytosis  
The invention provides a method of targeting an x-ray contrast agent to a specific population of cells or organ. Targeting may be accomplished by forming a complex of a radiopaque label with a...
5114707 Polycondensation silicone elastomer dosage forms for the controlled release of iodine values  
Polycondensation silicone elastomer dosage forms adapted for the continuous and controlled release of iodine values, notably to domestic water supplies for the treatment of the various disease...
5061484 Perfluorochemical emulsion with stabilized vesicles  
A stable perfluorochemical emulsion is provided which comprises perfluorochemical particles in stabilized vesicles. The vesicles comprise a biocompatible polymer formed by coating the...
4895876 Concentrated stable fluorochemical aqueous emulsions containing triglycerides  
A stable concentrated aqueous emulsion of perfluorochemical, a phospholipid and a triglyceride of fatty acids has been demonstrated which has enhanced stability, diminished particle size and...
Matches 1 - 50 out of 91 1 2 >